在STEMI中完全重血管化的效果:缺血驱动的再住院和心血管死亡率
Miha Sustersic1, Matjaz Bunc1,2
1Department of Cardiology, University Medical Centre Ljubljana, Zaloska 7, 1000 Ljubljana, Slovenia.
Journal of clinical medicine
|July 12, 2025
概括
在ST升高心肌梗塞 (STEMI) 患有多血管冠状动脉疾病 (MVD) 的患者中,完全重血管化 (CR) 显示出因缺血症导致的再住院和心血管死亡的综合终点较低. 然而,经过调整后,再血管化方法无法独立预测结果.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 临床结果研究研究
背景情况:
- 患有ST升高心肌梗塞 (STEMI) 和多血管冠状动脉疾病 (MVD) 的患者从完整的再血管化 (CR) 获益,而不是不完整的再血管化 (IR).
- 之前的试验没有显示CR的生存益处,但对重复血管化或再住院等综合终点有积极影响.
- 该研究通过检查长期的CR效应来解决STEMI再住院的重大医疗负担.
研究的目的:
- 调查完整的再血管 (CR) 与不完整的再血管 (IR) 对缺血驱动的再住院和心血管 (CV) 死亡的长期影响.
- 分析重血管化策略与MVD的STEMI患者的患者结果之间的关系.
主要方法:
- 对235名患有MVD的STEMI患者进行了回顾性分析,这些患者接受了初级穿皮冠状动脉干预 (PCI).
- 患者被分为CR (N=70) 或IR (N=165) 组.
- 主要终点是因缺血导致的再住院和心血管死亡率的复合,随访时间至少为6年.
主要成果:
- 与IR组相比,CR组的综合终点率 (32.9%) 显著较低 (47.3%) (日志排名p=0.025),主要是由于心血管死亡率较低 (12.9%对23.6%,日志排名p=0.047).
- 两组之间没有观察到因缺血导致的再住院率的显著差异 (log-rank p=0.206).
- 经过对混杂因素进行调整后,再血管化方法对心血管死亡率没有显著影响 (p=0.622). 结合终点的预测因素包括年龄,糖尿病,CKD,心脏性休克,CTO和因缺血导致的再住院.
结论:
- 虽然在MVD的STEMI患者中,CR与较低的缺血驱动的再住院和心血管死亡率的初始联合终点相关,但这种益处与其他风险因素无关.
- 随时出现的情况,如心脏性休克,晚期脏病和年龄较大,是不良结果的显著预测因素,无论重血管化策略如何.
- 这些发现强调了在患有MVD的STEMI患者中综合风险因素管理的重要性.
相关概念视频
01:30Acute Coronary Syndrome I: Introduction
80
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
80
01:28Acute Coronary Syndrome IV: Interprofessional Care
32
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
32
01:17Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
01:30Acute Coronary Syndrome III: Diagnostic Studies
25
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
25
01:27Coronary Artery Disease V: Interprofessional Care
37
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
37
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
47
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
47